Wang G - Search Results

1

Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.

Wang G, He J, Zhao J, Yun W, Xie C, Taub JW, Azmi A, Mohammad RM, Dong Y, Kong W, Guo Y, Ge Y. Wang G, et al. PLoS One. 2012;7(12):e52095. doi: 10.1371/journal.pone.0052095. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251689 Free PMC article.

2

Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines.

Guo Y, Xu X, Qi W, Xie C, Wang G, Zhang A, Ge Y. Guo Y, et al. Among authors: wang g. Mol Med Rep. 2012 Mar;5(3):734-8. doi: 10.3892/mmr.2011.738. Epub 2011 Dec 23. Mol Med Rep. 2012. PMID: 22200913

3

Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells.

Wang G, Edwards H, Caldwell JT, Buck SA, Qing WY, Taub JW, Ge Y, Wang Z. Wang G, et al. Among authors: wang z. PLoS One. 2013 Sep 30;8(9):e76662. doi: 10.1371/journal.pone.0076662. eCollection 2013. PLoS One. 2013. PMID: 24098799 Free PMC article.

4

Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer.

Chen S, Wang G, Niu X, Zhao J, Tan W, Wang H, Zhao L, Ge Y. Chen S, et al. Among authors: wang h, wang g. Cancer Lett. 2014 Jun 28;348(1-2):20-8. doi: 10.1016/j.canlet.2014.02.010. Epub 2014 Feb 15. Cancer Lett. 2014. PMID: 24534203

5

Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage.

Xie C, Edwards H, Caldwell JT, Wang G, Taub JW, Ge Y. Xie C, et al. Among authors: wang g. Mol Oncol. 2015 Feb;9(2):409-21. doi: 10.1016/j.molonc.2014.09.008. Epub 2014 Oct 2. Mol Oncol. 2015. PMID: 25308513 Free PMC article.

6

Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma.

Hanmod SS, Wang G, Edwards H, Buck SA, Ge Y, Taub JW, Wang Z. Hanmod SS, et al. Among authors: wang g, wang z. Pediatr Blood Cancer. 2015 Jan;62(1):52-9. doi: 10.1002/pbc.25232. Epub 2014 Oct 12. Pediatr Blood Cancer. 2015. PMID: 25308916

7

Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.

Wang G, Chen S, Edwards H, Cui X, Cui L, Ge Y. Wang G, et al. Oncol Rep. 2014 Dec;32(6):2789-94. doi: 10.3892/or.2014.3525. Epub 2014 Oct 3. Oncol Rep. 2014. PMID: 25333301

8

Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.

Wang G, Niu X, Zhang W, Caldwell JT, Edwards H, Chen W, Taub JW, Zhao L, Ge Y. Wang G, et al. Cancer Lett. 2015 Jan 28;356(2 Pt B):656-68. doi: 10.1016/j.canlet.2014.10.015. Epub 2014 Oct 18. Cancer Lett. 2015. PMID: 25458954 Free PMC article.

9

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.

Niu X, Zhao J, Ma J, Xie C, Edwards H, Wang G, Caldwell JT, Xiang S, Zhang X, Chu R, Wang ZJ, Lin H, Taub JW, Ge Y. Niu X, et al. Among authors: wang g, wang zj. Clin Cancer Res. 2016 Sep 1;22(17):4440-51. doi: 10.1158/1078-0432.CCR-15-3057. Epub 2016 Apr 21. Clin Cancer Res. 2016. PMID: 27103402 Free PMC article.

10

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.

Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, Taub JW, Lin H, Ge Y. Zhao J, et al. Among authors: wang g, wang y. Oncotarget. 2016 Jun 7;7(23):34785-99. doi: 10.18632/oncotarget.9185. Oncotarget. 2016. PMID: 27166183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45,790 results

Search Page